Data concerning the relation between increased levels of circulating sclerostin (a physiological inhibitor of bone formation) and bone turnover in patients with chronic renal failure (CRF) are limited. Therefore, the aim of this study was to evaluate associations between plasma sclerostin levels and calcium–phosphate disturbances, markers of bone turnover as well as inflammation in haemodialysis (HD) patients.
In plasma samples obtained in 150 stable HD patients (92 men) aged 40–70 years, levels of sclerostin, fibroblast growth factor (cFGF23), osteocalcin, the N-terminal propeptide of type I procollagen, C-terminal telopeptide of the alpha chain of type I collagen (β-CTx), and inflammatory markers (IL-6 and TNF-α) in addition to routine parameters (calcium, phosphorus, parathyroid hormone—iPTH, 25-OH-D, alkaline phosphatase) were measured.
Plasma sclerostin concentrations were significantly higher in HD men than women (2.61 vs. 1.88 ng/mL, p < 0.01). Patients with sclerostin levels above median were characterized by lower iPTH and IL-6, but higher cFGF23 and TNF-α (significantly only in men) concentrations. Plasma sclerostin concentration positively correlated with serum 25-OH-D (τ = 0.204), phosphorus (τ = 0.1482), and TNF-α (τ = 0.183) and inversely with iPTH (τ = − 0.255), alkaline phosphatase (τ = − 0.203), IL-6 (τ =− 0.201), and β-CTx (τ = − 0.099) levels. In multivariate regression analysis, variability of sclerostin levels was explained by sex and 25-OH-D and phosphorus levels.
Increased circulating sclerostin levels seem to reflect slower bone turnover in HD patients. Low levels of sclerostin are associated with vitamin D deficiency and good phosphates alignment.
Carvallo L, Henríquez B, Paredes R et al (2008) 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1-alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex. J Cell Physiol 214:740–749 CrossRefPubMed
Moe SM, Drueke TB, Block GA, Cannata-Andia JB et al (2009) KDIGO Clinical Practice Guidelines for the Diagnosis, Evaluation, Prevention and Treatment of Chronic Kidney Disease—Mineral and Bone Disorder (CKD-MBD); Kidney Disease Improving Global Outcomes (KDIGO) CKD-MBD, Work Group Am. Kidney Int Suppl (113): S1–S130. https://doi.org/10.1038/ki.2009.188
Almroth G, Lönn J, Uhlin F, Brudin L, Andersson B, Hahn-Zoric M (2015) Sclerostin, TNF-alpha and Interleukin-18 Correlate and are Together with Klotho Related to Other Growth Factors and Cytokines in Haemodialysis Patients. Scand J Immunol 83:58–63 CrossRef
de Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moysés RM, Jorgetti V (2015) Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int 87:1039–1045. https://doi.org/10.1038/ki.2014.372 CrossRefPubMed
Behets GJ, Viaene L, Meijers B, Blocki F, Brandenburg VM, Verhulst A, D’Haese PC, Evenepoel P (2017) Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD. PLoS ONE 12: e0176411. https://doi.org/10.1371/journal.pone.0176411. eCollection 2017 CrossRefPubMedPubMedCentral
Wijenayaka AR, Yang D, Prideaux M, Ito N, Kogawa M, Anderson PH et al (2015) 1a,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion. Mol Cell Endocrinol 413:1e11 CrossRef
Yadav AK, Kumar V, Banerjee D, Gupta KL, Jha V (2018) Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease. J Steroid Biochem Mol Biol 180:15–18. https://doi.org/10.1016/j.jsbmb.2018.01.007 CrossRefPubMed
Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370e8 CrossRef
- Relationship between plasma levels of sclerostin, calcium–phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients
- Springer Netherlands
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II